Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
Pharmaco-immunomodulatory therapy in COVID-19
The severe acute respiratory syndrome coronavirus 2 associated coronavirus disease 2019
(COVID-19) illness is a syndrome of viral replication in concert with a host inflammatory …
(COVID-19) illness is a syndrome of viral replication in concert with a host inflammatory …
Statins: could an old friend help in the fight against COVID‐19?
RR Rodrigues‐Diez, A Tejera‐Muñoz… - British journal of …, 2020 - Wiley Online Library
The COVID‐19 pandemic caused by the severe acute respiratory syndrome coronavirus 2
(SARS‐CoV‐2) has overwhelmed healthcare systems requiring the rapid development of …
(SARS‐CoV‐2) has overwhelmed healthcare systems requiring the rapid development of …
Association of COVID-19 with major arterial and venous thrombotic diseases: a population-wide cohort study of 48 million adults in England and Wales
Background: Infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
induces a prothrombotic state, but long-term effects of COVID-19 on incidence of vascular …
induces a prothrombotic state, but long-term effects of COVID-19 on incidence of vascular …
In-hospital use of statins is associated with a reduced risk of mortality among individuals with COVID-19
Statins are lipid-lowering therapeutics with favorable anti-inflammatory profiles and have
been proposed as an adjunct therapy for COVID-19. However, statins may increase the risk …
been proposed as an adjunct therapy for COVID-19. However, statins may increase the risk …
Association between antecedent statin use and decreased mortality in hospitalized patients with COVID-19
A Gupta, MV Madhavan, TJ Poterucha… - Nature …, 2021 - nature.com
Abstract The coronavirus disease 2019 (COVID-19) can result in a hyperinflammatory state,
leading to acute respiratory distress syndrome (ARDS), myocardial injury, and thrombotic …
leading to acute respiratory distress syndrome (ARDS), myocardial injury, and thrombotic …
The prognostic value of comorbidity for the severity of COVID-19: A systematic review and meta-analysis study
Background and objectives With the increase in the number of COVID-19 infections, the
global health apparatus is facing insufficient resources. The main objective of the current …
global health apparatus is facing insufficient resources. The main objective of the current …
Improved COVID‐19 outcomes following statin therapy: an updated systematic review and meta‐analysis
Background. Although vaccine rollout for COVID‐19 has been effective in some countries,
there is still an urgent need to reduce disease transmission and severity. We recently carried …
there is still an urgent need to reduce disease transmission and severity. We recently carried …
Statin therapy did not improve the in-hospital outcome of coronavirus disease 2019 (COVID-19) infection
Background and aims The coronavirus disease 2019 (COVID-19) number of death cases is
still increasing. One of the comorbidities associated with severe outcome and mortality of …
still increasing. One of the comorbidities associated with severe outcome and mortality of …
Statin use is associated with lower disease severity in COVID-19 infection
We aim to study the association of hyperlipidemia and statin use with COVID-19 severity. We
analysed a retrospective cohort of 717 patients admitted to a tertiary centre in Singapore for …
analysed a retrospective cohort of 717 patients admitted to a tertiary centre in Singapore for …
[HTML][HTML] Endothelial dysfunction in COVID-19: Current findings and therapeutic implications
MP Nägele, B Haubner, FC Tanner, F Ruschitzka… - atherosclerosis, 2020 - Elsevier
Abstract Coronavirus disease 2019 (COVID-19) increases the risk of several non-pulmonary
complications such as acute myocardial injury, renal failure or thromboembolic events. A …
complications such as acute myocardial injury, renal failure or thromboembolic events. A …